Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1990 Jun;85(6):1967–1973. doi: 10.1172/JCI114660

Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P-450IA2. A specific marker of dihydralazine-induced hepatitis.

M Bourdi 1, D Larrey 1, J Nataf 1, J Bernuau 1, D Pessayre 1, M Iwasaki 1, F P Guengerich 1, P H Beaune 1
PMCID: PMC296665  PMID: 2347920

Abstract

Sera from patients with dihydralazine-induced hepatitis were shown to contain anti-liver microsomal autoantibodies (anti-LM) by indirect immunofluorescence. These anti-LM antibodies were different from anti-liver/kidney microsomes (anti-LKM) 1 or 2 autoantibodies which have been previously described. Sera recognized a single 53,000 = Mr polypeptide in human liver microsomes as judged by immunoblotting, and the target antigen was identified as cytochrome P-450IA2 (P-450IA2) by (a) comparison of immunoblotting patterns with anti-human P-450IA2 and anti-rat P-450IA2 and with five anti-LM sera, and (b) specific immunoinhibition of microsomal ethoxyresorufin and phenacetin O-deethylation activities (both P-450IA2 supported reactions) by anti-LM antibodies. Finally, purified human P-450IA2 was recognized by these anti-LM sera. The anti-LM antibodies are specific for the disease because none of the other antisera tested behaved in the same manner as anti-LM, even those from patients treated with dihydralazine and without hepatic disease. A possible role of P-450IA2 in the metabolism of dihydralazine was suggested by competitive inhibition of ethoxyresorufin-O-deethylase observed in microsomal incubations. Thus, a new example is presented in which a cytochrome P-450 may be a target for autoantibodies in drug-induced hepatitis.

Full text

PDF
1967

Images in this article

1968Image
on p.1968
1968Image
on p.1968
1969Image
on p.1969
1969Image
on p.1969
1970Image
on p.1970
1970Image
on p.1970
1970Image
on p.1970
1970Image
on p.1970
1970Image
on p.1970

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beaune P. H., Cresteil T., Flinois J. P., Leroux J. P. Hydrophobic chromatography: a one-step method for the purification of human liver microsomal epoxide hydrolase. J Chromatogr. 1988 Apr 8;426(1):169–176. doi: 10.1016/s0378-4347(00)81939-8. [DOI] [PubMed] [Google Scholar]
  2. Beaune P., Flinois J. P., Kiffel L., Kremers P., Leroux J. P. Purification of a new cytochrome P-450 from human liver microsomes. Biochim Biophys Acta. 1985 Jul 5;840(3):364–370. doi: 10.1016/0304-4165(85)90216-8. [DOI] [PubMed] [Google Scholar]
  3. Beaune P., Kremers P., Letawe-Goujon F., Gielen J. E. Monoclonal antibodies against human liver cytochrome P-450. Biochem Pharmacol. 1985 Oct 1;34(19):3547–3552. doi: 10.1016/0006-2952(85)90732-4. [DOI] [PubMed] [Google Scholar]
  4. Boccaccio F., Attali P., Nataf J., Ink O., Fabre M., Pelletier G. Hépatite aiguë due à la dihydralazine. Gastroenterol Clin Biol. 1987 Aug-Sep;11(8-9):614–614. [PubMed] [Google Scholar]
  5. Butler M. A., Guengerich F. P., Kadlubar F. F. Metabolic oxidation of the carcinogens 4-aminobiphenyl and 4,4'-methylene-bis(2-chloroaniline) by human hepatic microsomes and by purified rat hepatic cytochrome P-450 monooxygenases. Cancer Res. 1989 Jan 1;49(1):25–31. [PubMed] [Google Scholar]
  6. Cresteil T., Beaune P., Celier C., Leroux J. P., Guengerich F. P. Cytochrome P-450 isoenzyme content and monooxygenase activities in rat liver: effect of ontogenesis and pretreatment by phenobarbital and 3-methylcholanthrene. J Pharmacol Exp Ther. 1986 Jan;236(1):269–276. [PubMed] [Google Scholar]
  7. Distlerath L. M., Reilly P. E., Martin M. V., Davis G. G., Wilkinson G. R., Guengerich F. P. Purification and characterization of the human liver cytochromes P-450 involved in debrisoquine 4-hydroxylation and phenacetin O-deethylation, two prototypes for genetic polymorphism in oxidative drug metabolism. J Biol Chem. 1985 Jul 25;260(15):9057–9067. [PubMed] [Google Scholar]
  8. Gueguen M., Meunier-Rotival M., Bernard O., Alvarez F. Anti-liver kidney microsome antibody recognizes a cytochrome P450 from the IID subfamily. J Exp Med. 1988 Aug 1;168(2):801–806. doi: 10.1084/jem.168.2.801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Guengerich F. P. Characterization of human microsomal cytochrome P-450 enzymes. Annu Rev Pharmacol Toxicol. 1989;29:241–264. doi: 10.1146/annurev.pa.29.040189.001325. [DOI] [PubMed] [Google Scholar]
  10. Guengerich F. P., Dannan G. A., Wright S. T., Martin M. V., Kaminsky L. S. Purification and characterization of liver microsomal cytochromes p-450: electrophoretic, spectral, catalytic, and immunochemical properties and inducibility of eight isozymes isolated from rats treated with phenobarbital or beta-naphthoflavone. Biochemistry. 1982 Nov 9;21(23):6019–6030. doi: 10.1021/bi00266a045. [DOI] [PubMed] [Google Scholar]
  11. Guengerich F. P., Martin M. V., Beaune P. H., Kremers P., Wolff T., Waxman D. J. Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism. J Biol Chem. 1986 Apr 15;261(11):5051–5060. [PubMed] [Google Scholar]
  12. Homberg J. C., Abuaf N., Helmy-Khalil S., Biour M., Poupon R., Islam S., Darnis F., Levy V. G., Opolon P., Beaugrand M. Drug-induced hepatitis associated with anticytoplasmic organelle autoantibodies. Hepatology. 1985 Sep-Oct;5(5):722–727. doi: 10.1002/hep.1840050504. [DOI] [PubMed] [Google Scholar]
  13. Homberg J. C., Andre C., Abuaf N. A new anti-liver-kidney microsome antibody (anti-LKM2) in tienilic acid-induced hepatitis. Clin Exp Immunol. 1984 Mar;55(3):561–570. [PMC free article] [PubMed] [Google Scholar]
  14. Jaiswal A. K., Nebert D. W., McBride O. W., Gonzalez F. J. Human P(3)450: cDNA and complete protein sequence, repetitive Alu sequences in the 3' nontranslated region, and localization of gene to chromosome 15. J Exp Pathol. 1987 Winter;3(1):1–17. [PubMed] [Google Scholar]
  15. Kenna J. G., Satoh H., Christ D. D., Pohl L. R. Metabolic basis for a drug hypersensitivity: antibodies in sera from patients with halothane hepatitis recognize liver neoantigens that contain the trifluoroacetyl group derived from halothane. J Pharmacol Exp Ther. 1988 Jun;245(3):1103–1109. [PubMed] [Google Scholar]
  16. Kiffel L., Loeper J., Homberg J. C., Leroux J. P. A human cytochrome P-450 is recognized by anti-liver/kidney microsome antibodies in autoimmune chronic hepatitis. Biochem Biophys Res Commun. 1989 Feb 28;159(1):283–289. doi: 10.1016/0006-291x(89)92435-2. [DOI] [PubMed] [Google Scholar]
  17. Kremers P., Beaune P., Cresteil T., de Graeve J., Columelli S., Leroux J. P., Gielen J. E. Cytochrome P-450 monooxygenase activities in human and rat liver microsomes. Eur J Biochem. 1981 Sep 1;118(3):599–606. doi: 10.1111/j.1432-1033.1981.tb05561.x. [DOI] [PubMed] [Google Scholar]
  18. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  19. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  20. Lubet R. A., Mayer R. T., Cameron J. W., Nims R. W., Burke M. D., Wolff T., Guengerich F. P. Dealkylation of pentoxyresorufin: a rapid and sensitive assay for measuring induction of cytochrome(s) P-450 by phenobarbital and other xenobiotics in the rat. Arch Biochem Biophys. 1985 Apr;238(1):43–48. doi: 10.1016/0003-9861(85)90138-9. [DOI] [PubMed] [Google Scholar]
  21. Maggiore G., Bernard O., Homberg J. C., Hadchouel M., Alvarez F., Hadchouel P., Odièvre M., Alagille D. Liver disease associated with anti-liver-kidney microsome antibody in children. J Pediatr. 1986 Mar;108(3):399–404. doi: 10.1016/s0022-3476(86)80880-0. [DOI] [PubMed] [Google Scholar]
  22. Manns M. P., Johnson E. F., Griffin K. J., Tan E. M., Sullivan K. F. Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1. J Clin Invest. 1989 Mar;83(3):1066–1072. doi: 10.1172/JCI113949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Meier U. T., Meyer U. A. Genetic polymorphism of human cytochrome P-450 (S)-mephenytoin 4-hydroxylase. Studies with human autoantibodies suggest a functionally altered cytochrome P-450 isozyme as cause of the genetic deficiency. Biochemistry. 1987 Dec 15;26(25):8466–8474. doi: 10.1021/bi00399a065. [DOI] [PubMed] [Google Scholar]
  24. Namkung M. J., Yang H. L., Hulla J. E., Juchau M. R. On the substrate specificity of cytochrome P450IIIA1. Mol Pharmacol. 1988 Nov;34(5):628–637. [PubMed] [Google Scholar]
  25. Nebert D. W., Nelson D. R., Adesnik M., Coon M. J., Estabrook R. W., Gonzalez F. J., Guengerich F. P., Gunsalus I. C., Johnson E. F., Kemper B. The P450 superfamily: updated listing of all genes and recommended nomenclature for the chromosomal loci. DNA. 1989 Jan-Feb;8(1):1–13. doi: 10.1089/dna.1.1989.8.1. [DOI] [PubMed] [Google Scholar]
  26. Pariente E. A., Pessayre D., Bernuau J., Degott C., Benhamou J. P. Dihydralazine hepatitis: report of a case and review of the literature. Digestion. 1983;27(1):47–52. doi: 10.1159/000198919. [DOI] [PubMed] [Google Scholar]
  27. Patten C. J., Ning S. M., Lu A. Y., Yang C. S. Acetone-inducible cytochrome P-450: purification, catalytic activity, and interaction with cytochrome b5. Arch Biochem Biophys. 1986 Dec;251(2):629–638. doi: 10.1016/0003-9861(86)90373-5. [DOI] [PubMed] [Google Scholar]
  28. Satoh H., Gillette J. R., Davies H. W., Schulick R. D., Pohl L. R. Immunochemical evidence of trifluoroacetylated cytochrome P-450 in the liver of halothane-treated rats. Mol Pharmacol. 1985 Nov;28(5):468–474. [PubMed] [Google Scholar]
  29. Satoh H., Martin B. M., Schulick A. H., Christ D. D., Kenna J. G., Pohl L. R. Human anti-endoplasmic reticulum antibodies in sera of patients with halothane-induced hepatitis are directed against a trifluoroacetylated carboxylesterase. Proc Natl Acad Sci U S A. 1989 Jan;86(1):322–326. doi: 10.1073/pnas.86.1.322. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Schneider T., Siegmund W., Zschiesche M., Kallwellis R., Scherber A. Zum qualitativen Nachweis von Metaboliten des Dihydralazins beim Menschen. Pharmazie. 1988 Jan;43(1):33–36. [PubMed] [Google Scholar]
  31. Sesardic D., Boobis A. R., Edwards R. J., Davies D. S. A form of cytochrome P450 in man, orthologous to form d in the rat, catalyses the O-deethylation of phenacetin and is inducible by cigarette smoking. Br J Clin Pharmacol. 1988 Oct;26(4):363–372. doi: 10.1111/j.1365-2125.1988.tb03393.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Shimada T., Iwasaki M., Martin M. V., Guengerich F. P. Human liver microsomal cytochrome P-450 enzymes involved in the bioactivation of procarcinogens detected by umu gene response in Salmonella typhimurium TA 1535/pSK1002. Cancer Res. 1989 Jun 15;49(12):3218–3228. [PubMed] [Google Scholar]
  33. Waxman D. J., Lapenson D. P., Krishnan M., Bernard O., Kreibich G., Alvarez F. Antibodies to liver/kidney microsome1 in chronic active hepatitis recognize specific forms of hepatic cytochrome P-450. Gastroenterology. 1988 Nov;95(5):1326–1331. doi: 10.1016/0016-5085(88)90368-x. [DOI] [PubMed] [Google Scholar]
  34. Wolf C. R., Hook J. B., Lock E. A. Differential destruction of cytochrome P-450-dependent monooxygenases in rat and mouse kidney following hexachloro-1:3-butadiene administration. Mol Pharmacol. 1983 Jan;23(1):206–212. [PubMed] [Google Scholar]
  35. Wrighton S. A., Campanile C., Thomas P. E., Maines S. L., Watkins P. B., Parker G., Mendez-Picon G., Haniu M., Shively J. E., Levin W. Identification of a human liver cytochrome P-450 homologous to the major isosafrole-inducible cytochrome P-450 in the rat. Mol Pharmacol. 1986 Apr;29(4):405–410. [PubMed] [Google Scholar]
  36. Zanger U. M., Hauri H. P., Loeper J., Homberg J. C., Meyer U. A. Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II. Proc Natl Acad Sci U S A. 1988 Nov;85(21):8256–8260. doi: 10.1073/pnas.85.21.8256. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES